Evidence map›Paper›PMID 36912833›Full record

ArticleJAMA network open2023

Incidence of SARS-CoV-2 Infection Among People Experiencing Homelessness in Toronto, Canada.

Lucie Richard, Rosane Nisenbaum, Michael Brown, Michael Liu, Cheryl Pedersen, Jesse I R Jenkinson, Sharmistha Mishra, Stefan Baral, Karen Colwill, Anne-Claude Gingras and 2 more

Full text read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucie RichardMAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Rosane NisenbaumMAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Michael BrownDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Michael LiuMAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Cheryl PedersenMAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Jesse I R JenkinsonMAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Sharmistha MishraMAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Stefan BaralDepartment of Epidemiology, John Hopkins University, Baltimore, Maryland.
Karen ColwillLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Anne-Claude GingrasLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Allison McGeerDepartment of Microbiology, Mount Sinai Hospital, Toronto, Toronto, Ontario, Canada.
Stephen W HwangMAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.

Funding

CIHR FDN VR5-173211
6 · The paper itself

Abstract

Importance: People experiencing homelessness are at high risk of SARS-CoV-2 infection. Incident infection rates have yet to be established in these communities and are needed to inform infection prevention guidance and related interventions. Objective: To quantify the SARS-CoV-2 incident infection rate among people experiencing homelessness in Toronto, Canada, in 2021 and 2022 and to assess factors associated with incident infection. Design, Setting, and Participants: This prospective cohort study was conducted among individuals aged 16 years and older who were randomly selected between June and September 2021 from 61 homeless shelters, temporary distancing hotels, and encampments in Toronto, Canada. Exposures: Self-reported housing characteristics, such as number sharing living space. Main Outcomes and Measures: Prevalence of prior SARS-CoV-2 infection in summer 2021, defined as self-reported or polymerase chain reaction (PCR)- or serology-confirmed evidence of infection at or before the baseline interview, and SARS-CoV-2 incident infection, defined as self-reported or PCR- or serology-confirmed infection among participants without history of infection at baseline. Factors associated with infection were assessed using modified Poisson regression with generalized estimating equations. Results: The 736 participants (415 of whom did not have SARS-CoV-2 infection at baseline and were included in the primary analysis) had a mean (SD) age of 46.1 (14.6) years; 486 (66.0%) self-identified as male. Of these, 224 (30.4% [95% CI, 27.4%-34.0%]) had a history of SARS-CoV-2 infection by summer 2021. Of the remaining 415 participants with follow-up, 124 experienced infection within 6 months, representing an incident infection rate of 29.9% (95% CI, 25.7%-34.4%), or 5.8% (95% CI, 4.8%-6.8%) per person-month. Report after onset of the SARS-CoV-2 Omicron variant was associated with incident infection, with an adjusted rate ratio (aRR) of 6.28 (95% CI, 3.94-9.99). Other factors associated with incident infection included recent immigration to Canada (aRR, 2.74 [95% CI, 1.64-4.58]) and alcohol consumption over the past interval (aRR, 1.67 [95% CI, 1.12-2.48]). Self-reported housing characteristics were not significantly associated with incident infection. Conclusions and Relevance: In this longitudinal study of people experiencing homelessness in Toronto, SARS-CoV-2 incident infection rates were high in 2021 and 2022, particularly once the Omicron variant became dominant in the region. Increased focus on homelessness prevention is needed to more effectively and equitably protect these communities.

Indexed as

COVID-19Ill-Housed PersonsCanadaHumansIncidenceLongitudinal StudiesMaleProspective StudiesSARS-CoV-2

Identifiers

PMID36912833
PMCPMC10011938

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read75
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.